English
Home > Products > 241479-74-3

China 241479-74-3 Factory

We are commitment to offer the competitive price ,outstanding products quality, as well as fast delivery for 241479-74-3,CAS NO 241479-74-3,Isavuconazole intermediate,Isavuconazole advance intermediate,(αS,βR)-β-(2,5-Difluorophenyl)-β-hydroxy, We have ISO 9001 Certification and qualified this product or service .in excess of 16 years experiences in manufacturing and designing, so our goods featured with very best high-quality and aggressive rate. Welcome cooperation with us!
241479-74-3, During the short years, we serve our clients honestly as Quality First, Integrity Prime, Delivery Timely, which has earned us an outstanding reputation and an impressive client care portfolio. Looking forward to working with you Now!

Related Products

Hot Products

  • Estradiol Enanthate

    Estradiol Enanthate

    Product Name:Estradiol Enanthate
    Molecular Formula:C25H36O3
    Molecular Weight:384.56
    CAS Registry Number;4956-37-0
  • Potassium chloroplatinate

    Potassium chloroplatinate

    Product Name:Potassium chloroplatinate
    Molecular Formula:Cl6KPt-
    Molecular Weight:446.88
    CAS Registry Number:16921-30-5
  • Tirzepatide

    Tirzepatide

    Product Name:Tirzepatide
    Molecular Formula:C225H348N48O68
    Molecular Weight;4813.45
    CAS Registry Number;2023788-19-2
  • Beleodaq

    Beleodaq

    Product Name:Beleodaq
    Molecular Formula:C15H14N2O4S
    Molecular Weight;318.35
    CAS Registry Number;866323-14-0
  • 2,4,5-Trichloroaniline

    2,4,5-Trichloroaniline

    Product Name:2,4,5-Trichloroaniline
    Molecular Formula:C6H4Cl3N
    Molecular Weight:196.46
    CAS Registry Number:636-30-6
  • 2,3-Pyrazinedicarboxylic acid

    2,3-Pyrazinedicarboxylic acid

    Product Name:2,3-Pyrazinedicarboxylic acid
    Molecular Formula:C6H4N2O4
    Molecular Weight:168.11
    CAS Registry Number:89-01-0
  • Related Blog
  • Reviews

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

Related Search

CAS NO 241479-74-3

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept